Characteristic | N | Pre COVID, N = 451 | Post COVID, N = 251 | Overall, N = 702 | p-value |
---|---|---|---|---|---|
Large center | 246 (55%) | 127 (51%) | 373 (53%) | 0.300 | |
Gender (M) | 702 | 234 (52%) | 147 (59%) | 381 (54%) | 0.144 |
Age (d), median (IQR) | 702 | 55 (33, 125) | 73 (40, 178) | 62 (34, 142) | 0.039 |
Ethnicity | 702 | 0.236 | |||
Caucasian | 343 (76%) | 180 (72%) | 523 (75%) | ||
Arabic | 55 (12%) | 29 (12%) | 84 (12%) | ||
African | 20 (4.4%) | 17 (6.8%) | 37 (5.3%) | ||
Asiatic | 22 (4.9%) | 12 (4.8%) | 34 (4.8%) | ||
Hispanic | 8 (1.8%) | 6 (2.4%) | 14 (2.0%) | ||
Mixed ethnicity | 3 (0.7%) | 6 (2.4%) | 9 (1.3%) | ||
Afro-American | 0 (0%) | 1 (0.4%) | 1 (0.1%) | ||
Weight (kg), median(IQR) | 700 | 4.60 (3.70, 6.30) | 5.00 (4.00, 6.95) | 4.80 (3.80, 6.50) | 0.056 |
Comorbidities | 702 | 59 (13%) | 52 (21%) | 111 (16%) | 0.039 |
Ex-premature | 702 | 61 (14%) | 20 (8.0%) | 81 (12%) | 0.056 |
Respiratory | 702 | 18 (4%) | 13 (5.2%) | 31 (4.4%) | 0.5 |
Cardiac | 702 | 17 (3.8%) | 9 (3.6%) | 26 (3.7%) | > 0.9 |
Neurologic | 702 | 17 (3.8%) | 5 (2.0%) | 22 (3.1%) | 0.2 |
Syndromic | 702 | 13 (2.9%) | 9 (3.6%) | 22 (3.1%) | 0.6 |
PIM 3 score (%), median (IQR) | 673 | 0.46 (0.37, 0.62) | 0.52 (0.38, 0.67) | 0.48 (0.37, 0.63) | 0.046 |
FiO2 at admission, median(IQR) | 394 | 0.35 (0.30, 0.40) | 0.40 (0.30, 0.45) | 0.40 (0.30, 0.40) | 0.052 |
Lactates at admission (mmol/L) median(IQR) | 297 | 1.40 (1.00, 2.12) | 1.38 (0.90, 2.20) | 1.40 (1.00, 2.20) | 0.325 |
RSV cases | 538 | 287 (84%) | 155 (79%) | 442 (82%) | 0.465 |
Sepsis | 538 | 1 (0.2%) | 3 (1%) | 4 (1%) | 0.187 |
Bacterial infection | 538 | 16 (5%) | 21 (11%) | 37 (7%) | 0.800 |
Co-infection (2 microorganisms isolated) | 538 | 33 (10%) | 48 (25%) | 81 (15%) | 0.600 |